These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 16293596)
1. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Notari M; Neviani P; Santhanam R; Blaser BW; Chang JS; Galietta A; Willis AE; Roy DC; Caligiuri MA; Marcucci G; Perrotti D Blood; 2006 Mar; 107(6):2507-16. PubMed ID: 16293596 [TBL] [Abstract][Full Text] [Related]
2. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Chang JS; Santhanam R; Trotta R; Neviani P; Eiring AM; Briercheck E; Ronchetti M; Roy DC; Calabretta B; Caligiuri MA; Perrotti D Blood; 2007 Aug; 110(3):994-1003. PubMed ID: 17475908 [TBL] [Abstract][Full Text] [Related]
3. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha. Ferrari-Amorotti G; Keeshan K; Zattoni M; Guerzoni C; Iotti G; Cattelani S; Donato NJ; Calabretta B Blood; 2006 Aug; 108(4):1353-62. PubMed ID: 16670262 [TBL] [Abstract][Full Text] [Related]
4. Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. Guerzoni C; Bardini M; Mariani SA; Ferrari-Amorotti G; Neviani P; Panno ML; Zhang Y; Martinez R; Perrotti D; Calabretta B Blood; 2006 May; 107(10):4080-9. PubMed ID: 16418324 [TBL] [Abstract][Full Text] [Related]
5. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph Peter B; Eisenwort G; Sadovnik I; Bauer K; Willmann M; Rülicke T; Berger D; Stefanzl G; Greiner G; Hoermann G; Keller A; Wolf D; Čulen M; Winter GE; Hoffmann T; Schiefer AI; Sperr WR; Zuber J; Mayer J; Valent P Am J Hematol; 2022 Sep; 97(9):1215-1225. PubMed ID: 35794848 [TBL] [Abstract][Full Text] [Related]
6. Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. Coluccia AM; Vacca A; Duñach M; Mologni L; Redaelli S; Bustos VH; Benati D; Pinna LA; Gambacorti-Passerini C EMBO J; 2007 Mar; 26(5):1456-66. PubMed ID: 17318191 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity. He N; Li G; Liu J; Liu W; Tian R; Ma D Front Immunol; 2024; 15():1452035. PubMed ID: 39635534 [TBL] [Abstract][Full Text] [Related]
8. Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial. Short NJ; Nguyen D; Jabbour E; Senapati J; Zeng Z; Issa GC; Abbas H; Nasnas C; Qiao W; Huang X; Borthakur G; Chien K; Haddad FG; Pemmaraju N; Karrar OS; Nguyen D; Konopleva M; Kantarjian H; Ravandi F Lancet Haematol; 2024 Nov; 11(11):e839-e849. PubMed ID: 39303729 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
10. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice. Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242 [TBL] [Abstract][Full Text] [Related]
11. A Blog-Based Study of Autistic Adults' Experiences of Aloneness and Connection and the Interplay with Well-Being: Corpus-Based and Thematic Analyses. Petty S; Allen S; Pickup H; Woodier B Autism Adulthood; 2023 Dec; 5(4):437-449. PubMed ID: 38116056 [TBL] [Abstract][Full Text] [Related]
12. The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy. Decroos A; Meddour S; Demoy M; Piccirilli N; Rousselot P; Nicolini FE; Ragot S; Gombert JM; Herbelin A; Barbarin A; Cayssials E Front Immunol; 2024; 15():1473139. PubMed ID: 39620210 [TBL] [Abstract][Full Text] [Related]
14. Australia in 2030: what is our path to health for all? Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362 [TBL] [Abstract][Full Text] [Related]
15. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Pan C; Olsen JV; Daub H; Mann M Mol Cell Proteomics; 2009 Dec; 8(12):2796-808. PubMed ID: 19651622 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of Existing BCR-ABL Baseline Mutations and Associated Haplotype (NmR) Among CML Patients with Diverse IM Response: A Hospital-based Study from North-East India. Hazarika G; Kalita MJ; Das PP; Kalita S; Dutta K; Lahkar L; Rajkonwar A; Idris MG; Khamo V; Kusre G; Medhi S Biochem Genet; 2024 Dec; 62(6):4804-4816. PubMed ID: 38363412 [TBL] [Abstract][Full Text] [Related]
17. Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis. Glenton C; Paulsen E; Agarwal S; Gopinathan U; Johansen M; Kyaddondo D; Munabi-Babigumira S; Nabukenya J; Nakityo I; Namaganda R; Namitala J; Neumark T; Nsangi A; Pakenham-Walsh NM; Rashidian A; Royston G; Sewankambo N; Tamrat T; Lewin S Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015705. PubMed ID: 39189465 [TBL] [Abstract][Full Text] [Related]
18. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
19. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]